Winton Group’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,541	Closed	-$113K	–	1153
2019 Q1	$113K	Buy	+10,541	New	+$113K	﹤0.01%	1024
2018 Q2	–	Sell	-7,214	Closed	-$205K	–	1041
2018 Q1	$205K	Buy	+7,214	New	+$205K	0.01%	1100